Immunohistochemical analysis of RHAMM expression in normal and neoplastic human tissues: a cell cycle protein with distinctive expression in mitotic cells and testicular germ cells
Immunohistochemical analysis of RHAMM expression in normal and neoplastic human tissues: a cell cycle protein with distinctive expression in mitotic cells and testicular germ cells |
|
https://doi.org/10.18632/oncotarget.24939
Yao-Tseng Chen,
Zhengming Chen,
and Yi-Chieh Nancy Du
|
| 20941-20952 |
DHX9 regulates production of hepatitis B virus-derived circular RNA and viral protein levels
DHX9 regulates production of hepatitis B virus-derived circular RNA and viral protein levels |
|
https://doi.org/10.18632/oncotarget.25104
Kazuma Sekiba,
Motoyuki Otsuka,
Motoko Ohno,
Takahiro Kishikawa,
Mari Yamagami,
Tatsunori Suzuki,
Rei Ishibashi,
Takahiro Seimiya,
Eri Tanaka,
and Kazuhiko Koike
|
| 20953-20964 |
20(S)-protopanaxadiol regio-selectively targets androgen receptor: anticancer effects in castration-resistant prostate tumors
20(S)-protopanaxadiol regio-selectively targets androgen receptor: anticancer effects in castration-resistant prostate tumors |
|
https://doi.org/10.18632/oncotarget.24695
Mohamed Ben-Eltriki,
Subrata Deb,
Mohamed Hassona,
Gray Meckling,
Ladan Fazli,
Mei Yieng Chin,
Nada Lallous,
Takeshi Yamazaki,
William Jia,
Paul S. Rennie,
Artem Cherkasov,
and Emma S. Tomlinson Guns
|
| 20965-20978 |
Wnt5a-induced cell migration is associated with the aggressiveness of estrogen receptor-positive breast cancer
Wnt5a-induced cell migration is associated with the aggressiveness of estrogen receptor-positive breast cancer |
|
https://doi.org/10.18632/oncotarget.24761
Yoshie Kobayashi,
Takayuki Kadoya,
Ai Amioka,
Hideaki Hanaki,
Shinsuke Sasada,
Norio Masumoto,
Hideki Yamamoto,
Koji Arihiro,
Akira Kikuchi,
and Morihito Okada
|
| 20979-20992 |
Cancer cell-selective, clathrin-mediated endocytosis of aptamer decorated nanoparticles
Cancer cell-selective, clathrin-mediated endocytosis of aptamer decorated nanoparticles |
|
https://doi.org/10.18632/oncotarget.24772
Shira Engelberg,
Julia Modrejewski,
Johanna G. Walter,
Yoav D. Livney,
and Yehuda G. Assaraf
|
| 20993-21006 |
Selective dissociation between LSD1 and GFI1B by a LSD1 inhibitor NCD38 induces the activation of ERG super-enhancer in erythroleukemia cells
Selective dissociation between LSD1 and GFI1B by a LSD1 inhibitor NCD38 induces the activation of ERG super-enhancer in erythroleukemia cells |
|
https://doi.org/10.18632/oncotarget.24774
Ryusuke Yamamoto,
Masahiro Kawahara,
Shinji Ito,
Junko Satoh,
Goichi Tatsumi,
Masakatsu Hishizawa,
Takayoshi Suzuki,
and Akira Andoh
|
| 21007-21021 |
Targeting the mevalonate pathway is a novel therapeutic approach to inhibit oncogenic FoxM1 transcription factor in human hepatocellular carcinoma
Targeting the mevalonate pathway is a novel therapeutic approach to inhibit oncogenic FoxM1 transcription factor in human hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.24781
Satoshi Ogura,
Yuichi Yoshida,
Tomohide Kurahashi,
Mayumi Egawa,
Kunimaro Furuta,
Shinichi Kiso,
Yoshihiro Kamada,
Hayato Hikita,
Hidetoshi Eguchi,
Hisakazu Ogita,
Yuichiro Doki,
Masaki Mori,
Tomohide Tatsumi,
and Tetsuo Takehara
|
| 21022-21035 |
Increasing aggressiveness of patient-derived xenograft models of cervix carcinoma during serial transplantation
Increasing aggressiveness of patient-derived xenograft models of cervix carcinoma during serial transplantation |
|
https://doi.org/10.18632/oncotarget.24783
Catherine S. Wegner,
Anette Hauge,
Lise Mari K. Andersen,
Ruixia Huang,
Trude G. Simonsen,
Jon-Vidar Gaustad,
and Einar K. Rofstad
|
| 21036-21051 |
Long noncoding RNAs are associated with metabolic and cellular processes in the jejunum mucosa of pre-weaning calves in response to different diets
Long noncoding RNAs are associated with metabolic and cellular processes in the jejunum mucosa of pre-weaning calves in response to different diets |
|
https://doi.org/10.18632/oncotarget.24898
Rosemarie Weikard,
Frieder Hadlich,
Harald M. Hammon,
Doerte Frieten,
Caroline Gerbert,
Christian Koch,
Georg Dusel,
and Christa Kuehn
|
| 21052-21069 |
Histogram analysis parameters of dynamic contrast-enhanced magnetic resonance imaging can predict histopathological findings including proliferation potential, cellularity, and nucleic areas in head and neck squamous cell carcinoma
Histogram analysis parameters of dynamic contrast-enhanced magnetic resonance imaging can predict histopathological findings including proliferation potential, cellularity, and nucleic areas in head and neck squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.24920
Alexey Surov,
Hans Jonas Meyer,
Leonard Leifels,
Anne-Kathrin Höhn,
Cindy Richter,
and Karsten Winter
|
| 21070-21077 |
Long term deficiency of vitamin D in germ cell testicular cancer survivors
Long term deficiency of vitamin D in germ cell testicular cancer survivors |
|
https://doi.org/10.18632/oncotarget.24925
Lucia Nappi,
Margaret Ottaviano,
Pasquale Rescigno,
Ladan Fazli,
Martin E. Gleave,
Vincenzo Damiano,
Sabino De Placido,
and Giovannella Palmieri
|
| 21078-21085 |
Establishment of preclinical chemotherapy models for gastroenteropancreatic neuroendocrine carcinoma
Establishment of preclinical chemotherapy models for gastroenteropancreatic neuroendocrine carcinoma |
|
https://doi.org/10.18632/oncotarget.24930
Akihiro Ohmoto,
Masami Suzuki,
Erina Takai,
Hirofumi Rokutan,
Yuko Fujiwara,
Chigusa Morizane,
Kazuyoshi Yanagihara,
Tatsuhiro Shibata,
and Shinichi Yachida
|
| 21086-21099 |
Overexpressing TPTE2 (TPIP), a homolog of the human tumor suppressor gene PTEN, rescues the abnormal phenotype of the PTEN–/– mutant
Overexpressing TPTE2 (TPIP), a homolog of the human tumor suppressor gene PTEN, rescues the abnormal phenotype of the PTEN–/– mutant |
|
https://doi.org/10.18632/oncotarget.24941
Daniel F. Lusche,
Emma C. Buchele,
Kanoe B. Russell,
Benjamin A. Soll,
Michele I. Vitolo,
Michael R. Klemme,
Deborah J. Wessels,
and David R. Soll
|
| 21100-21121 |
Cross-platform comparison for the detection of RAS mutations in cfDNA (ddPCR Biorad detection assay, BEAMing assay, and NGS strategy)
Cross-platform comparison for the detection of RAS mutations in cfDNA (ddPCR Biorad detection assay, BEAMing assay, and NGS strategy) |
|
https://doi.org/10.18632/oncotarget.24950
Jessica Garcia,
Julien Forestier,
Eric Dusserre,
Anne-Sophie Wozny,
Florence Geiguer,
Patrick Merle,
Claire Tissot,
Carole Ferraro-Peyret,
Frederick S. Jones,
Daniel L. Edelstein,
Valérie Cheynet,
Claire Bardel,
Gaelle Vilchez,
Zhenyu Xu,
Pierre Paul Bringuier,
Marc Barritault,
Karen Brengle-Pesce,
Marielle Guillet,
Marion Chauvenet,
Brigitte Manship,
Marie Brevet,
Claire Rodriguez-Lafrasse,
Valérie Hervieu,
Sébastien Couraud,
Thomas Walter,
and Léa Payen
|
| 21122-21131 |
Clinical characteristics of non-small cell lung cancer harboring mutations in exon 20 of EGFR or HER2
Clinical characteristics of non-small cell lung cancer harboring mutations in exon 20 of EGFR or HER2 |
|
https://doi.org/10.18632/oncotarget.24958
Masayuki Takeda,
Kazuko Sakai,
Hidetoshi Hayashi,
Kaoru Tanaka,
Junko Tanizaki,
Takayuki Takahama,
Koji Haratani,
Kazuto Nishio,
and Kazuhiko Nakagawa
|
| 21132-21140 |
Esophageal cancer cells resistant to T-DM1 display alterations in cell adhesion and the prostaglandin pathway
Esophageal cancer cells resistant to T-DM1 display alterations in cell adhesion and the prostaglandin pathway |
|
https://doi.org/10.18632/oncotarget.24975
Juliette Sauveur,
Eva-Laure Matera,
Kamel Chettab,
Philippe Valet,
Jerome Guitton,
Ariel Savina,
and Charles Dumontet
|
| 21141-21155 |
LpMab-23-recognizing cancer-type podoplanin is a novel predictor for a poor prognosis of early stage tongue cancer
LpMab-23-recognizing cancer-type podoplanin is a novel predictor for a poor prognosis of early stage tongue cancer |
|
https://doi.org/10.18632/oncotarget.24986
Akihiro Miyazaki,
Hiromi Nakai,
Tomoko Sonoda,
Yoshihiko Hirohashi,
Mika K. Kaneko,
Yukinari Kato,
Yoshihiko Sawa,
and Hiroyoshi Hiratsuka
|
| 21156-21165 |
Metabolic changes associated with metformin potentiates Bcl-2 inhibitor, Venetoclax, and CDK9 inhibitor, BAY1143572 and reduces viability of lymphoma cells
Metabolic changes associated with metformin potentiates Bcl-2 inhibitor, Venetoclax, and CDK9 inhibitor, BAY1143572 and reduces viability of lymphoma cells |
|
https://doi.org/10.18632/oncotarget.24989
Vineela Chukkapalli,
Leo I. Gordon,
Parameswaran Venugopal,
Jeffrey A. Borgia,
and Reem Karmali
|
| 21166-21181 |
MYC gene amplification is a rare event in atypical fibroxanthoma and pleomorphic dermal sarcoma
MYC gene amplification is a rare event in atypical fibroxanthoma and pleomorphic dermal sarcoma |
|
https://doi.org/10.18632/oncotarget.24997
Timo Gaiser,
Daniela Hirsch,
Azadeh Orouji,
Marisa Bach,
Peter Kind,
Doris Helbig,
Alexander Quaas,
Jochen Utikal,
Alexander Marx,
and Maria Rita Gaiser
|
| 21182-21189 |
Mean platelet volume as a predictive marker for venous thromboembolism in patients treated for Hodgkin lymphoma
Mean platelet volume as a predictive marker for venous thromboembolism in patients treated for Hodgkin lymphoma |
|
https://doi.org/10.18632/oncotarget.25002
Joanna Rupa-Matysek,
Lidia Gil,
Marta Barańska,
Dominik Dytfeld,
and Mieczysław Komarnicki
|
| 21190-21200 |
Comparison of coronary artery bypass grafting and percutaneous coronary intervention in patients with heart failure with reduced ejection fraction and multivessel coronary artery disease
Comparison of coronary artery bypass grafting and percutaneous coronary intervention in patients with heart failure with reduced ejection fraction and multivessel coronary artery disease |
|
https://doi.org/10.18632/oncotarget.25006
Michal Hawranek,
Michal O. Zembala,
Gasior Mariusz,
Hrapkowicz Tomasz,
Pyka Łukasz,
Daniel Cieśla,
and Zembala Marian
|
| 21201-21210 |
Chemopreventive activity of celastrol in drug–resistant human colon carcinoma cell cultures
Chemopreventive activity of celastrol in drug–resistant human colon carcinoma cell cultures |
|
https://doi.org/10.18632/oncotarget.25014
Helena Moreira,
Anna Szyjka,
and Kazimierz Gąsiorowski
|
| 21211-21223 |
GSTM1, GSTT1, and GSTP1 polymorphisms and colorectal cancer risk in Polish nonsmokers
GSTM1, GSTT1, and GSTP1 polymorphisms and colorectal cancer risk in Polish nonsmokers |
|
https://doi.org/10.18632/oncotarget.25031
Justyna Klusek,
Anna Nasierowska-Guttmejer,
Artur Kowalik,
Iwona Wawrzycka,
Piotr Lewitowicz,
Magdalena Chrapek,
and Stanisław Głuszek
|
| 21224-21230 |
BI2536 induces mitotic catastrophe and radiosensitization in human oral cancer cells
BI2536 induces mitotic catastrophe and radiosensitization in human oral cancer cells |
|
https://doi.org/10.18632/oncotarget.25035
Chieh-Yuan Cheng,
Chung-Ji Liu,
Yu-Chuen Huang,
Shu-Hua Wu,
Hsu-Wei Fang,
and Yu-Jen Chen
|
| 21231-21243 |
Effects of CB2 and TRPV1 receptors’ stimulation in pediatric acute T-lymphoblastic leukemia
Effects of CB2 and TRPV1 receptors’ stimulation in pediatric acute T-lymphoblastic leukemia |
|
https://doi.org/10.18632/oncotarget.25052
Francesca Punzo,
Iolanda Manzo,
Chiara Tortora,
Elvira Pota,
Velia D’ Angelo,
Giulia Bellini,
Alessandra Di Paola,
Federica Verace,
Fiorina Casale,
and Francesca Rossi
|
| 21244-21258 |
Predicting hepatocellular carcinoma through cross-talk genes identified by risk pathways
Predicting hepatocellular carcinoma through cross-talk genes identified by risk pathways |
|
https://doi.org/10.18632/oncotarget.24915
Lei Liu,
Lin Pang,
Yunfeng Wang,
Ming Hu,
Zhuo Shao,
Diwei Huo,
Denan Zhang,
Hongbo Xie,
Jingbo Yang,
Qiuqi Liu,
and Xiujie Chen
|
| 21259-21267 |
STAT3-activated CD36 facilitates fatty acid uptake in chronic lymphocytic leukemia cells
STAT3-activated CD36 facilitates fatty acid uptake in chronic lymphocytic leukemia cells |
|
https://doi.org/10.18632/oncotarget.25066
Uri Rozovski,
David M. Harris,
Ping Li,
Zhiming Liu,
Preetesh Jain,
Alessandra Ferrajoli,
Jan Burger,
Phillip Thompson,
Nitin Jain,
William Wierda,
Michael J. Keating,
and Zeev Estrov
|
| 21268-21280 |
Prognostic value of the DNA integrity index in patients with malignant lung tumors
Prognostic value of the DNA integrity index in patients with malignant lung tumors |
|
https://doi.org/10.18632/oncotarget.25086
Dimple Y. Chudasama,
Zeynep Aladag,
Mayla I. Felicien,
Marcia Hall,
Julie Beeson,
Nizar Asadi,
Yori Gidron,
Emmanouil Karteris,
and Vladimir B. Anikin
|
| 21281-21288 |
CRM1/XPO1 expression in pancreatic adenocarcinoma correlates with survivin expression and the proliferative activity
CRM1/XPO1 expression in pancreatic adenocarcinoma correlates with survivin expression and the proliferative activity |
|
https://doi.org/10.18632/oncotarget.25088
David M. Saulino,
Pamela S. Younes,
Jennifer M. Bailey,
and Mamoun Younes
|
| 21289-21295 |
Could a plant derived protein potentiate the anticancer effects of a stem cell in brain cancer?
Could a plant derived protein potentiate the anticancer effects of a stem cell in brain cancer? |
|
https://doi.org/10.18632/oncotarget.25090
Camila Ramalho Bonturi,
Helena Motaln,
Mariana Cristina Cabral Silva,
Bruno Ramos Salu,
Marlon Vilela de Brito,
Luciana de Andrade Luz Costa,
Heron Fernandes Vieira Torquato,
Natalia Neto dos Santos Nunes,
Edgar Julian Paredes-Gamero,
Tamara Lah Turnšek,
and Maria Luiza Vilela Oliva
|
| 21296-21312 |
The effect of antiviral therapy on serum lipid profiles in chronic hepatitis C
The effect of antiviral therapy on serum lipid profiles in chronic hepatitis C |
|
https://doi.org/10.18632/oncotarget.25092
Batbold Batsaikhan,
Ching-I Huang,
Ming-Lun Yeh,
Chung-Feng Huang,
Nei-Jen Hou,
Zu-Yau Lin,
Shinn-Cherng Chen,
Jee-Fu Huang,
Ming-Lung Yu,
Wan-Long Chuang,
Jin-Ching Lee,
and Chia-Yen Dai
|
| 21313-21321 |
SMAR1 inhibits Wnt/β-catenin signaling and prevents colorectal cancer progression
SMAR1 inhibits Wnt/β-catenin signaling and prevents colorectal cancer progression |
|
https://doi.org/10.18632/oncotarget.25093
Nandaraj Taye,
Aftab Alam,
Suvankar Ghorai,
Deya Ghosh Chatterji,
Apoorva Parulekar,
Devraj Mogare,
Snahlata Singh,
Pallabi Sengupta,
Subhrangsu Chatterjee,
Manoj Kumar Bhat,
Manas Kumar Santra,
Prabhakar Budha Salunkhe,
Susan Kling Finston,
and Samit Chattopadhyay
|
| 21322-21336 |
IgG4-related kidney disease: the effects of a Rituximab-based immunosuppressive therapy
IgG4-related kidney disease: the effects of a Rituximab-based immunosuppressive therapy |
|
https://doi.org/10.18632/oncotarget.25095
Giacomo Quattrocchio,
Antonella Barreca,
Andrea Demarchi,
Laura Solfietti,
Giulietta Beltrame,
Roberta Fenoglio,
Michela Ferro,
Paola Mesiano,
Stefano Murgia,
Giulio Del Vecchio,
Carlo Massara,
Cristiana Rollino,
and Dario Roccatello
|
| 21337-21347 |
Comparison of infectivity and spread between HSV-1 and HSV-2 based oncolytic viruses on tumor cells with different receptor expression profiles
Comparison of infectivity and spread between HSV-1 and HSV-2 based oncolytic viruses on tumor cells with different receptor expression profiles |
|
https://doi.org/10.18632/oncotarget.25096
Xinping Fu,
Lihua Tao,
Pin-Yi Wang,
Timothy P. Cripe,
and Xiaoliu Zhang
|
| 21348-21358 |
Multi-institution analysis of racial disparity among African-American men eligible for prostate cancer active surveillance
Multi-institution analysis of racial disparity among African-American men eligible for prostate cancer active surveillance |
|
https://doi.org/10.18632/oncotarget.25103
Michael Dinizo,
Weichung Shih,
Young Suk Kwon,
Daniel Eun,
Adam Reese,
Laura Giusto,
Edouard J. Trabulsi,
Bertram Yuh,
Nora Ruel,
Daniel Marchalik,
Jonathan Hwang,
Shilajit D. Kundu,
Scott Eggener,
and Isaac Yi Kim
|
| 21359-21365 |
Proteomic screening identifies the zonula occludens protein ZO-1 as a new partner for ADAM12 in invadopodia-like structures
Proteomic screening identifies the zonula occludens protein ZO-1 as a new partner for ADAM12 in invadopodia-like structures |
|
https://doi.org/10.18632/oncotarget.25106
Bassil Dekky,
Michael Ruff,
Dominique Bonnier,
Vincent Legagneux,
and Nathalie Théret
|
| 21366-21382 |
Signature program: a platform of basket trials
Signature program: a platform of basket trials |
|
https://doi.org/10.18632/oncotarget.25109
Eric D. Slosberg,
Barinder P. Kang,
Julio Peguero,
Matthew Taylor,
Todd M. Bauer,
Donald A. Berry,
Fadi Braiteh,
Alexander Spira,
Funda Meric-Bernstam,
Steven Stein,
Sarina A. Piha-Paul,
and August Salvado
|
| 21383-21395 |
Transformation of mouse T cells requires MYC and AKT activity in conjunction with inhibition of intrinsic apoptosis
Transformation of mouse T cells requires MYC and AKT activity in conjunction with inhibition of intrinsic apoptosis |
|
https://doi.org/10.18632/oncotarget.25113
Kari Högstrand,
Stephanie Darmanin,
TachaZi Plym Forshell,
and Alf Grandien
|
| 21396-21410 |
Deregulation of methylation of transcribed-ultra conserved regions in colorectal cancer and their value for detection of adenomas and adenocarcinomas
Deregulation of methylation of transcribed-ultra conserved regions in colorectal cancer and their value for detection of adenomas and adenocarcinomas |
|
https://doi.org/10.18632/oncotarget.25115
Anastasia E. Kottorou,
Anna G. Antonacopoulou,
Foteinos-Ioannis D. Dimitrakopoulos,
Georgia Diamantopoulou,
Chaido Sirinian,
Melpomeni Kalofonou,
Theodoros Theodorakopoulos,
Chrysa Oikonomou,
Evangelos C. Katsakoulis,
Angelos Koutras,
Thomas Makatsoris,
Nikos Demopoulos,
Georgia Stephanou,
Michalis Stavropoulos,
Konstantinos C. Thomopoulos,
and Haralabos P. Kalofonos
|
| 21411-21428 |
MTBP inhibits the Erk1/2-Elk-1 signaling in hepatocellular carcinoma
MTBP inhibits the Erk1/2-Elk-1 signaling in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.25117
Atul Ranjan,
Swathi V. Iyer,
Christopher Ward,
Tim Link,
Francisco J. Diaz,
Animesh Dhar,
Ossama W. Tawfik,
Steven A. Weinman,
Yoshiaki Azuma,
Tadahide Izumi,
and Tomoo Iwakuma
|
| 21429-21443 |
Functional significance of co-occurring mutations in PIK3CA and MAP3K1 in breast cancer
Functional significance of co-occurring mutations in PIK3CA and MAP3K1 in breast cancer |
|
https://doi.org/10.18632/oncotarget.25118
Alvaro Avivar-Valderas,
Robert McEwen,
Amir Taheri-Ghahfarokhi,
Larissa S. Carnevalli,
Elizabeth L. Hardaker,
Marcello Maresca,
Kevin Hudson,
Elizabeth A. Harrington,
and Francisco Cruzalegui
|
| 21444-21458 |
Higher enterococcus counts indicate a lower risk of colorectal adenomas: a prospective cohort study
Higher enterococcus counts indicate a lower risk of colorectal adenomas: a prospective cohort study |
|
https://doi.org/10.18632/oncotarget.25130
Atsuko Kawano,
Hideki Ishikawa,
Michihiro Mutoh,
Hiroyuki Kubota,
Kazunori Matsuda,
Hirokazu Tsuji,
Kazumasa Matsumoto,
Koji Nomoto,
Ryuichiro Tanaka,
Tomiyo Nakamura,
Keiji Wakabayashi,
and Toshiyuki Sakai
|
| 21459-21467 |
Acquired resistance to everolimus in aromatase inhibitor-resistant breast cancer
Acquired resistance to everolimus in aromatase inhibitor-resistant breast cancer |
|
https://doi.org/10.18632/oncotarget.25133
Mariko Kimura,
Toru Hanamura,
Kouki Tsuboi,
Yosuke Kaneko,
Yuri Yamaguchi,
Toshifumi Niwa,
Kazutaka Narui,
Itaru Endo,
and Shin-Ichi Hayashi
|
| 21468-21477 |
Targeted nanoparticle delivery of therapeutic antisense microRNAs presensitizes glioblastoma cells to lower effective doses of temozolomide in vitro and in a mouse model
Targeted nanoparticle delivery of therapeutic antisense microRNAs presensitizes glioblastoma cells to lower effective doses of temozolomide in vitro and in a mouse model |
|
https://doi.org/10.18632/oncotarget.25135
Meenakshi Malhotra,
Thillai Veerapazham Sekar,
Jeyarama S. Ananta,
Rammohan Devulapally,
Rayhaneh Afjei,
Husam A. Babikir,
Ramasamy Paulmurugan,
and Tarik F. Massoud
|
| 21478-21494 |
A protein folding molecular imaging biosensor monitors the effects of drugs that restore mutant p53 structure and its downstream function in glioblastoma cells
A protein folding molecular imaging biosensor monitors the effects of drugs that restore mutant p53 structure and its downstream function in glioblastoma cells |
|
https://doi.org/10.18632/oncotarget.25138
Ramasamy Paulmurugan,
Rayhaneh Afjei,
Thillai V. Sekar,
Husam A. Babikir,
and Tarik F. Massoud
|
| 21495-21511 |
Antibody-assisted target identification reveals afatinib, an EGFR covalent inhibitor, down-regulating ribonucleotide reductase
Antibody-assisted target identification reveals afatinib, an EGFR covalent inhibitor, down-regulating ribonucleotide reductase |
|
https://doi.org/10.18632/oncotarget.25177
Cheng-Han Yu,
Chi-Chi Chou,
Hsin-Fang Tu,
Wei-Chieh Huang,
Ya-Yeh Ho,
Kay-Hooi Khoo,
Ming-Shyue Lee,
and Geen-Dong Chang
|
| 21512-21529 |
Coffee consumption and risk of myocardial infarction: a dose-response meta-analysis of observational studies
Coffee consumption and risk of myocardial infarction: a dose-response meta-analysis of observational studies |
|
https://doi.org/10.18632/oncotarget.23947
Long Mo,
Wei Xie,
Xiaoqun Pu,
and Dongsheng Ouyang
|
| 21530-21540 |
The fallopian tube microbiome: implications for reproductive health
The fallopian tube microbiome: implications for reproductive health |
|
https://doi.org/10.18632/oncotarget.25059
Elise S. Pelzer,
Dana Willner,
Melissa Buttini,
Louise M. Hafner,
Christina Theodoropoulos,
and Flavia Huygens
|
| 21541-21551 |
Patients with high serum substance P levels previously to liver transplantation for hepatocellular carcinoma have higher risk of one-year liver transplantation mortality
Patients with high serum substance P levels previously to liver transplantation for hepatocellular carcinoma have higher risk of one-year liver transplantation mortality |
|
https://doi.org/10.18632/oncotarget.25097
Leonardo Lorente,
Sergio T. Rodriguez,
Pablo Sanz,
Antonia Pérez-Cejas,
Javier Padilla,
Dácil Díaz,
Antonio González,
María M. Martín,
Alejandro Jiménez,
Purificación Cerro,
and Manuel A. Barrera
|
| 21552-21559 |
Transarterial chemoembolization as a substitute to radiofrequency ablation for treating Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma
Transarterial chemoembolization as a substitute to radiofrequency ablation for treating Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.25108
Kentaro Ishikawa,
Tetsuhiro Chiba,
Yoshihiko Ooka,
Eiichiro Suzuki,
Sadahisa Ogasawara,
Takahiro Maeda,
Masayuki Yokoyama,
Masanori Inoue,
Toru Wakamatsu,
Yuko Kusakabe,
Tomoko Saito,
Akinobu Tawada,
Makoto Arai,
Tatsuo Kanda,
Hitoshi Maruyama,
Fumio Imazeki,
and Naoya Kato
|
| 21560-21568 |
A pilot study of peptide vaccines for VEGF receptor 1 and 2 in patients with recurrent/progressive high grade glioma
A pilot study of peptide vaccines for VEGF receptor 1 and 2 in patients with recurrent/progressive high grade glioma |
|
https://doi.org/10.18632/oncotarget.25131
Shunsuke Shibao,
Ryo Ueda,
Katsuya Saito,
Ryogo Kikuchi,
Hideaki Nagashima,
Atsuhiro Kojima,
Hiroshi Kagami,
Eriel Sandika Pareira,
Hikaru Sasaki,
Shinobu Noji,
Yutaka Kawakami,
Kazunari Yoshida,
and Masahiro Toda
|
| 21569-21579 |
A myriad of roles of miR-25 in health and disease
A myriad of roles of miR-25 in health and disease |
|
https://doi.org/10.18632/oncotarget.24662
Márta Sárközy,
Zsuzsanna Kahán,
and Tamás Csont
|
| 21580-21612 |
Targeted therapies in the management of locally advanced and metastatic pancreatic cancer: a systematic review
Targeted therapies in the management of locally advanced and metastatic pancreatic cancer: a systematic review |
|
https://doi.org/10.18632/oncotarget.25085
Anjali V. Sheahan,
Andrew V. Biankin,
Christopher R. Parish,
and Levon M. Khachigian
|
| 21613-21627 |
Correction: Diagnostic and prognostic utilities of humoral fibulin-3 in malignant pleural mesothelioma: Evidence from a meta-analysis
Correction: Diagnostic and prognostic utilities of humoral fibulin-3 in malignant pleural mesothelioma: Evidence from a meta-analysis |
|
https://doi.org/10.18632/oncotarget.25301
Dongxu Pei,
Yongwei Li,
Xinwei Liu,
Sha Yan,
Xiaolan Guo,
Xiaona Xu,
and Xiaoxia Guo
|
| 21628-21628 |
Correction: Chidamide and decitabine can synergistically induce apoptosis of Hodgkin lymphoma cells by up-regulating the expression of PU.1 and KLF4
Correction: Chidamide and decitabine can synergistically induce apoptosis of Hodgkin lymphoma cells by up-regulating the expression of PU.1 and KLF4 |
|
https://doi.org/10.18632/oncotarget.25302
Tao Jiang,
Fujue Wang,
Lianjie Hu,
Xiaomin Cheng,
Yuhuan Zheng,
Ting Liu,
and Yongqian Jia
|
| 21629-21629 |
